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THE EFFECT OF LOW INTENSITY PULSED ULTRASOUND TREATMENT
COMBINED WITH MESENCHYMAL STROMAL CELL INJECTION FOR
CARTILAGE REGENERATION IN A KNEE OSTEOCHONDRAL DEFECT
MODEL OF RATS.
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Purpose: Once cartilage is injured, it rarely recovers spontaneously,
because of their poor intrinsic healing capacity. Cell transplantation
therapy is anticipated to regenerate cartilage defect. Mesenchymal
stromal cell (MSC) is one of expecting cell sources for cartilage repair
due to their character including the capability which differentiate into
chondrocyte. However there were few study that veriﬁed efﬁcacy and
safety of aftertreatment post cell transplantation. There were some
reports that low intensity pulsed ultrasound (LIPUS), which is used for
bone fracture treatment, could stimulate MSC differentiation into
osteo-/chondro-cyte in vitro. The aim of this study was to investigate
whether LIPUS treatment combined with cell therapy could affect car-
tilage regeneration for a knee osteochondral defect model of rats.
Methods: This study was approved by the animal research committee
of our facility. An osteochondral defect of 1mm diameter was created on
both femur grooves of twelve Wistar rats at 12-week old. Four weeks
after creation of the defect, 1.0 106 allogeneic bone marrow MSCs
diluted with phosphate-buffered saline (PBS) was transplanted into
right knee joint by intra-articular injection and PBS without MSC was
injected into left knee joint. The rats were divided into 2 interventions:
without or with LIPUS treatment. Two days after injection, the rats with
LIPUS were subjected to LIPUS treatment according to parameters
borrowed from those for bone fracture treatment, 20 min/day, 5 days/
week, to both knee joints. After 4 and 8 weeks intervention, the rats
were euthanized, femora were removed and divided into four groups:
Control group (PBS injection), LIPUS group (PBS injection with LIPUS
treatment), MSC group (MSC injection) and MSCL group (MSC injection
with LIPUS treatment). The 6-mm thick serial sections of the femur
specimen stained with safranin-O and hematoxylin-eosin were exam-
ined and scored with Wakitani’s cartilage repair score. The collagen
type I and II expressions were also observed by immunohistochemical
methods.
Results: Four weeks after intra-articular injection, the histological score
were as follows, Control group: 8.7±2.36, LIPUS group: 4.7±1.31, MSC
group: 4.7±1.31, MSCL group: 4.3±0.65. The defect area was ﬁlled with
repair tissue which wasn’t hyaline cartilage in Control group. Repair
tissue in Control group was mostly expressed by collagen type I, but
collagen type II expression was restricted in deep zone. In LIPUS, MSC
andMSCL group, repair tissue mostly included hyaline cartilage like cell
morphology, and showed SO staining intensity in middle zone. The
repair tissue in these three group was thicker than Control group. The
expression of collagen type II was observed in wide range of repair
tissue in LIPUS, MSC and MSCL group, but the expression of type I
collagen was observed through surface and middle zone in these
groups. Eight weeks after intra-articular injection, the histological score
were as follows, Control group: 7.7±2.36, LIPUS group: 7.0±1.96, MSC
group: 4.7±1.31, MSCL group: 4.0±0.00. In Control and LIPUS group,
ﬁbroblast like cell morphology was observed and SO intensity was
reduced. The expression of collagen type II was attenuated through
surface to middle zone in Control group, while attenuated in surface
zone of LIPUS group. In MSC and MSCL group, hyaline cartilage like cell
morphology was observed in repair tissue, but the SO intensity was
reduced. The expression of collagen type II was attenuated in surface
zone of MSC and MSCL group. The expression of collagen type I was
located in surface zone of all group or middle zone in some specimen.
Conclusions: It might be indicated LIPUS treatment or MSC injection
could stimulate cartilage regeneration in 4 weeks after MSC injection,
but repaired cartilage stimulated by LIPUS treatment was deteriorated
in 8 weeks after MSC injection. In this experiment condition there
might be little interactive effect between LIPUS and MSC injection for
cartilage repair.214
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Purpose: Bone marrow stimulation is in use clinically as a treatment
option for cartilage defects. Theoretically mesenchymal stem cells
reside in bone marrow are induced into cartilage defects followed by
cartilage repair with this technique. Although mostly good clinical
results were reported, histology revealed repaired cartilage was ﬁbro-
to hyaline-like cartilage.
The aim of this study is to investigate whether systemic administration
of G-CSF, stimulant of bone marrow, could improve the quality of
repaired tissue using full thickness articular cartilage defect model of a
rabbit.
Methods: Thirty 12week-old male New Zealand White rabbits were
divided into three groups.
The low dose group (n¼10) received daily 10mg/kg of G-CSF, the high
dose group (n¼10) 50mg/kg, subcutaneous injections for three days,
prior to creating cartilage defects. To the control group (n¼10), saline
was administered for three days.
48 hours after the ﬁrst injection, a 5.2mm diameter cylindrical osteo-
chondral defect was created in the center of the femoral trochlea.
4, 12 weeks after the procedure, status of repaired tissue was evaluated
by macroscopically as well as microscopically.
Results: Macroscopically, the defect ﬁllings and the tissue qualities
were better in G-CSF group than in the control group at 4 weeks. (High
dose group showed better than the low dose group.)
Qualities of repaired cartilage were better in the G-CSF group at 12
weeks but the defect ﬁllings were better in the control group, which
assumed to be hypertrophy of ﬁbrocartilage.
Conclusions: Macroscopically, G-CSF administration prior to bone
marrow stimulation was effective in modifying quality of repaired tis-
sue.
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Purpose: Osteoarthritis (OA) is a degenerative joint disease that is
caused by an imbalance in cartilage degeneration and synthesis, which
results in pain and low quality of life in patients. It is a major health
problem in elderly generation. Besides painkillers and anti-inﬂamma-
tory drugs alleviating OA symptoms, disease-modifying osteoarthritis
drugs (DMOADs) have drawn much attention. Given the fact that gene
products stimulate chondrogenesis or break down cartilage matrix,
delivery of therapeutic genes as DMOADs to the articular cartilage is a
promising strategy for the treatment of OA. However, there are con-
cerns regarding safety and efﬁciency on the introduction of nucleic
acids in vivo. Although viral transduction shows high efﬁciency of gene
introduction, its application is limited because of strong immunoge-
nicity and toxicity. Plasmid DNA transfection has a risk of insertion into
host genome. Messenger RNA (mRNA) introduction would directly
induce the expression of therapeutic proteins in target cells without any
risk of insertion mutagenesis. A biocompatible gene carrier based on
self-assembly of a polyethylene glycol (PEG)-polyamino acid block
copolymer, polyplex nanomicelle, was recently shown to achieve in vivo
mRNA introduction by solving two major limitations for the in vivo
mRNA delivery, instability and immunogenicity of mRNA. In this study,
we examined the efﬁcacy of the polyplex nanomicelle-mediated mRNA
introduction into the articular cartilage of intact or surgically-induced
OA knees in mice, aiming to apply this strategy to the treatment of OA
